Condition: Cancer · Liver Cirrhosis · Chronic Hepatitis · Sponsor: Helio Genomics
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
This description comes directly from the study's public registry record.
Clinical Operations Manager · 6263500537 · octavia@heliogenomics.com
Always discuss trial participation with your own doctor first.
| Torrance Memorial Physician Network - Cancer Care | Redondo Beach, California, United States | Active Not Recruiting |
| Allina Health, Virginia Piper Cancer Institute | Coon Rapids, Minnesota, United States | Recruiting |
| Virginia Piper Cancer Institute Mercy Hospital-Unity Campus | Fridley, Minnesota, United States | Recruiting |
| VPCI Oncology Research | Minneapolis, Minnesota, United States | Recruiting |
| Methodist LeBonheur Healthcare | Memphis, Tennessee, United States | Recruiting |
| Liver Center of Texas | Dallas, Texas, United States | Recruiting |
| Methodist Hospital | Richardson, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05181826